Mihael H. Polymeropoulos
2016
In 2016, Mihael H. Polymeropoulos earned a total compensation of $7.2M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 204% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,483,200 |
|---|---|
| Option Awards | $2,156,000 |
| Salary | $618,000 |
| Stock Awards | $2,900,000 |
| Other | $28,257 |
| Total | $7,185,457 |
Polymeropoulos received $2.9M in stock awards, accounting for 40% of the total pay in 2016.
Polymeropoulos also received $1.5M in non-equity incentive plan, $2.2M in option awards, $618K in salary and $28.3K in other compensation.
Rankings
In 2016, Mihael H. Polymeropoulos' compensation ranked 892nd out of 14,075 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 93.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 892 out of 14,075 | 94th |
Division Manufacturing | 291 out of 5,488 | 95th |
Major group Chemicals And Allied Products | 77 out of 1,900 | 96th |
Industry group Drugs | 49 out of 1,543 | 97th |
Industry Pharmaceutical Preparations | 41 out of 1,173 | 97th |
Source: SEC filing on April 27, 2017.
Polymeropoulos' colleagues
We found four more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2016.